CO4950564A1 - Nuevo proceso para la preparacion de una sustancia farmaco- logimante activa - Google Patents
Nuevo proceso para la preparacion de una sustancia farmaco- logimante activaInfo
- Publication number
- CO4950564A1 CO4950564A1 CO98026855A CO98026855A CO4950564A1 CO 4950564 A1 CO4950564 A1 CO 4950564A1 CO 98026855 A CO98026855 A CO 98026855A CO 98026855 A CO98026855 A CO 98026855A CO 4950564 A1 CO4950564 A1 CO 4950564A1
- Authority
- CO
- Colombia
- Prior art keywords
- racemic
- optically active
- general formula
- compounds
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 230000003287 optical effect Effects 0.000 abstract 1
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Abstract
Un proceso para la preparación de compuestos racémicos uópticamente activos con la fórmula general (VI)- en los que X representa un átomo de halógeno - o sus sales, caracterizado porque se transforma un nuevo compuesto racémico u ópticamente activo con la fórmula general (VII)- en el que X representa un átomo de halógeno - en el compuesto racémico u ópticamente activo con la fórmula general (VIII) - en el que X representa un átomo de halógeno - y, si se desea, los compuestos racémicos resultantes con la fórmula general (VIII) se resuelven en sus isómeros ópticamente activos y, luego, mediante un cierre de anillo, a través de un método conocido per se, los compuestos con la fórmula general (VIII) se transforman en los compuestos racémicos u ópticamente activos con la fórmula general (VI), y, si se desea, los compuestos racémicos u ópticamente activos con la fórmula general (VI) se resuelven en sus isómeros ópticos y/o se transforman en sus sales y/o el compuesto racémico u ópticamente activo es liberado desde sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9700885A HU222283B1 (hu) | 1997-05-13 | 1997-05-13 | Eljárás tieno[3,2-c]piridin-származékok előállítására |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4950564A1 true CO4950564A1 (es) | 2000-09-01 |
Family
ID=90014236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98026855A CO4950564A1 (es) | 1997-05-13 | 1998-05-13 | Nuevo proceso para la preparacion de una sustancia farmaco- logimante activa |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6180793B1 (es) |
| EP (1) | EP0981529B1 (es) |
| KR (1) | KR100428238B1 (es) |
| CN (1) | CN1109036C (es) |
| AR (1) | AR014349A1 (es) |
| AT (1) | ATE212025T1 (es) |
| AU (1) | AU735702B2 (es) |
| BR (1) | BR9809112B1 (es) |
| CA (1) | CA2289623C (es) |
| CO (1) | CO4950564A1 (es) |
| CZ (1) | CZ292820B6 (es) |
| DE (1) | DE69803176T2 (es) |
| DK (1) | DK0981529T3 (es) |
| DZ (1) | DZ2487A1 (es) |
| EE (1) | EE03925B1 (es) |
| EG (1) | EG21973A (es) |
| ES (1) | ES2172141T3 (es) |
| HK (1) | HK1027350A1 (es) |
| HR (1) | HRP980240B1 (es) |
| HU (1) | HU222283B1 (es) |
| ID (1) | ID23018A (es) |
| IL (1) | IL132774A0 (es) |
| IS (1) | IS1883B (es) |
| ME (1) | ME01636B (es) |
| MY (1) | MY121299A (es) |
| NO (1) | NO325419B1 (es) |
| NZ (1) | NZ501577A (es) |
| PL (1) | PL194859B1 (es) |
| PT (1) | PT981529E (es) |
| RS (1) | RS49626B (es) |
| RU (1) | RU2172315C1 (es) |
| SA (1) | SA98190583B1 (es) |
| SK (1) | SK283700B6 (es) |
| TR (1) | TR199902783T2 (es) |
| TW (1) | TW552263B (es) |
| UA (1) | UA66359C2 (es) |
| WO (1) | WO1998051689A1 (es) |
| ZA (1) | ZA983921B (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2769313B1 (fr) * | 1997-10-06 | 2000-04-21 | Sanofi Sa | Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese |
| HU226421B1 (en) * | 1998-11-09 | 2008-12-29 | Sanofi Aventis | Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides |
| IN191030B (es) * | 2001-01-24 | 2003-09-13 | Cadila Healthcare Ltd | |
| US6495691B1 (en) | 2001-07-06 | 2002-12-17 | Brantford Chemicals Inc. | Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives |
| US6767913B2 (en) | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
| US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
| ITMI20020933A1 (it) * | 2002-05-03 | 2003-11-03 | Danimite Dipharma S P A | Procedimento per la sintesi di clopidogrel |
| IL166593A0 (en) | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel | |
| US6800759B2 (en) | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
| US6812363B2 (en) * | 2002-10-15 | 2004-11-02 | Usv Limited | Racemization of optically active 2-substituted phenyl glycine esters |
| US20060100231A1 (en) * | 2003-03-10 | 2006-05-11 | Hetero Drugs Limited | Amorphous clopidogrel hydrogen sulfate |
| EP1603920A1 (en) | 2003-03-12 | 2005-12-14 | Cadila Healthcare Ltd. | Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate |
| GB0321256D0 (en) * | 2003-09-11 | 2003-10-08 | Generics Uk Ltd | Novel crystalline compounds |
| EP1680430B1 (en) | 2003-11-03 | 2010-01-20 | Cadila Healthcare Ltd. | Processes for preparing form i of (s)-(+)- clopidogrel bisulfate |
| CA2457459A1 (en) * | 2004-02-11 | 2005-08-11 | Brantford Chemicals Inc. | Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate |
| KR100553398B1 (ko) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
| US20060154957A1 (en) * | 2004-09-21 | 2006-07-13 | Nina Finkelstein | Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| TW200640932A (en) * | 2005-02-24 | 2006-12-01 | Teva Pharma | Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| KR100681512B1 (ko) | 2005-03-08 | 2007-02-09 | 주식회사 한서켐 | 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법 |
| KR101235117B1 (ko) | 2005-12-26 | 2013-02-20 | 에스케이케미칼주식회사 | 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법 |
| KR20090013794A (ko) * | 2006-04-27 | 2009-02-05 | 인드-스위프트 래버러토리즈 리미티드 | 클로피도그렐 히드로겐 설페이트의 다형태의 제조방법 |
| US20090247569A1 (en) * | 2006-08-03 | 2009-10-01 | Claude Singer | Process for Preparing Clopidogrel Bisulphate |
| DK2064217T3 (da) | 2006-09-04 | 2011-05-09 | Ranbaxy Lab Ltd | Forbedret fremgangsmåde til fremstilling af clopidogrel og dets farmaceutisk acceptable salte |
| EP1980563A1 (en) | 2007-04-09 | 2008-10-15 | BATTULA, Srinivasa Reddy | Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate |
| EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
| US20090264460A1 (en) * | 2008-04-21 | 2009-10-22 | Mamta Mishra | Clopidogrel pharmaceutical formulations |
| KR100990949B1 (ko) | 2008-06-09 | 2010-10-29 | 엔자이텍 주식회사 | 클로피도그렐 및 그의 유도체의 제조방법 |
| EP2346879A1 (en) * | 2008-10-24 | 2011-07-27 | Sandoz AG | A process for the preparation of s-clopidogrel |
| US8563690B2 (en) * | 2008-11-03 | 2013-10-22 | The Board Of Trustees Of The University Of Illinois | Modulation of platelet aggregation |
| CN101544655B (zh) * | 2009-05-05 | 2012-07-04 | 上海医药集团股份有限公司 | 噻吩并[3，2-c]吡啶衍生物的制备方法 |
| CN101863899B (zh) * | 2010-06-21 | 2013-03-20 | 常州制药厂有限公司 | 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法 |
| KR20170004282A (ko) | 2015-07-02 | 2017-01-11 | 류종렬 | 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓 |
| KR20170004283A (ko) | 2015-07-02 | 2017-01-11 | 류종렬 | 그립부가 개선된 쉐이크 핸드형 탁구 라켓 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2530247B1 (fr) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
| FR2608607B1 (fr) | 1986-12-23 | 1989-04-28 | Sanofi Sa | Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues |
| FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
| FR2652575B1 (fr) * | 1989-09-29 | 1992-01-24 | Sanofi Sa | Procede de preparation d'acides alpha-bromo phenylacetiques. |
| FR2664596B1 (fr) * | 1990-07-10 | 1994-06-10 | Sanofi Sa | Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese. |
-
1997
- 1997-05-13 HU HU9700885A patent/HU222283B1/hu active IP Right Grant
-
1998
- 1998-05-06 HR HR980240A patent/HRP980240B1/xx not_active IP Right Cessation
- 1998-05-08 ZA ZA983921A patent/ZA983921B/xx unknown
- 1998-05-11 AT AT98921670T patent/ATE212025T1/de active
- 1998-05-11 WO PCT/HU1998/000048 patent/WO1998051689A1/en active IP Right Grant
- 1998-05-11 DE DE69803176T patent/DE69803176T2/de not_active Expired - Lifetime
- 1998-05-11 SK SK1516-99A patent/SK283700B6/sk not_active IP Right Cessation
- 1998-05-11 ME MEP-1999-587A patent/ME01636B/me unknown
- 1998-05-11 IL IL13277498A patent/IL132774A0/xx not_active IP Right Cessation
- 1998-05-11 RU RU99126506/04A patent/RU2172315C1/ru active
- 1998-05-11 BR BRPI9809112-3A patent/BR9809112B1/pt not_active IP Right Cessation
- 1998-05-11 CN CN98805036A patent/CN1109036C/zh not_active Expired - Lifetime
- 1998-05-11 NZ NZ501577A patent/NZ501577A/en not_active IP Right Cessation
- 1998-05-11 AU AU74448/98A patent/AU735702B2/en not_active Expired
- 1998-05-11 TR TR1999/02783T patent/TR199902783T2/xx unknown
- 1998-05-11 EE EEP199900488A patent/EE03925B1/xx unknown
- 1998-05-11 EP EP98921670A patent/EP0981529B1/en not_active Expired - Lifetime
- 1998-05-11 CA CA002289623A patent/CA2289623C/en not_active Expired - Fee Related
- 1998-05-11 CZ CZ19993939A patent/CZ292820B6/cs not_active IP Right Cessation
- 1998-05-11 KR KR10-1999-7010466A patent/KR100428238B1/ko not_active IP Right Cessation
- 1998-05-11 ES ES98921670T patent/ES2172141T3/es not_active Expired - Lifetime
- 1998-05-11 PT PT98921670T patent/PT981529E/pt unknown
- 1998-05-11 PL PL336693A patent/PL194859B1/pl unknown
- 1998-05-11 DK DK98921670T patent/DK0981529T3/da active
- 1998-05-11 US US09/423,549 patent/US6180793B1/en not_active Expired - Lifetime
- 1998-05-11 RS YUP-587/99A patent/RS49626B/sr unknown
- 1998-05-12 MY MYPI98002116A patent/MY121299A/en unknown
- 1998-05-12 EG EG52098A patent/EG21973A/xx active
- 1998-05-12 DZ DZ980098A patent/DZ2487A1/xx active
- 1998-05-13 AR ARP980102220A patent/AR014349A1/es active IP Right Grant
- 1998-05-13 CO CO98026855A patent/CO4950564A1/es unknown
- 1998-06-12 TW TW087109424A patent/TW552263B/zh not_active IP Right Cessation
- 1998-09-27 SA SA98190583A patent/SA98190583B1/ar unknown
- 1998-11-05 UA UA99126785A patent/UA66359C2/uk unknown
- 1998-11-05 ID IDW991592A patent/ID23018A/id unknown
-
1999
- 1999-11-11 IS IS5244A patent/IS1883B/is unknown
- 1999-11-12 NO NO19995533A patent/NO325419B1/no not_active IP Right Cessation
-
2000
- 2000-10-10 HK HK00106408A patent/HK1027350A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4950564A1 (es) | Nuevo proceso para la preparacion de una sustancia farmaco- logimante activa | |
| EA199800140A1 (ru) | Композиции с контролируемым высвобождением пароксетина | |
| ES2190396T3 (es) | Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| PA8426801A1 (es) | Composiciones farmaceuticas para el tratamiento de la rinitis. | |
| GT199900119A (es) | Jarabe antihistaminico estabilizado. | |
| CO4820391A1 (es) | Compuestos hipolipidemicos de benzotiazepina | |
| ATE248153T1 (de) | Neue benzoxazole | |
| DK0897375T3 (da) | Fremgangsmåde til fremstilling af en strålingshærdelig overtrækssammensætning til optiske glasfibre, som har forlænget levetid på lager | |
| ES2130686T3 (es) | Procedimiento para la preparacion de metalocenil-fosfinas opticamente activas. | |
| MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
| CO5720995A2 (es) | Compuesto novedoso | |
| BR0011597A (pt) | Método para separar compostos orgânicos análogos e resina de troca iÈnica | |
| DK0912537T3 (da) | Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer | |
| CO5601045A2 (es) | Procedimiento para la fabricacion de compuestos organicos | |
| ES2091324T3 (es) | Proceso para la preparacion de aspartama a partir de una dicetopiperazina y nuevos compuestos intermedios y derivados para dicho proceso. | |
| DK1027348T3 (da) | 2-(2'-hydroxyphenyl)benzotriazoler anvendt som UV-stabilisatorer | |
| NO20016151L (no) | Fremstilling av substituerte piperidin-4-oner | |
| BRPI0411308A8 (pt) | Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
| CO4700282A1 (es) | Compuestos | |
| BR9507381A (pt) | Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos | |
| BR9806193A (pt) | Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm | |
| ECSP077384A (es) | Compuestos tricíclicos que contienen heteroátomos | |
| ES2189108T3 (es) | Nuevas oxazinas dissustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| UY26507A1 (es) | Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparación, medicamentos que contienen estos compuestos, así como el uso de estos compuestos para la preparación de medicamentos | |
| ES2190602T3 (es) | Procedimiento para la obtencion de los acidos 3-ciano-2,4-dihalogeno-5-fluor-benzoicos. |